Hematopoietic stem and progenitor cells are differentially mobilized depending on the duration of Flt3-ligand administration
- 15 January 2010
- journal article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 95 (7), 1061-1067
- https://doi.org/10.3324/haematol.2009.016691
Abstract
Flt3-ligand is a cytokine that induces relatively slow mobilization of hematopoietic cells in animals and humans in vivo. This provides a time-frame to study hematopoietic stem and progenitor cell migration kinetics in detail. Mice were injected with Flt3-ligand (10 microg/day, intraperitoneally) for 3, 5, 7 and 10 days. Mobilization of hematopoietic stem and progenitor cells was studied using colony-forming-unit granulocyte/monocyte and cobblestone-area-forming-cell assays. The radioprotective capacity of mobilized peripheral blood mononuclear cells was studied by transplantation of 1.5 x 10(6) Flt3-ligand-mobilized peripheral blood mononuclear cells into lethally irradiated (9.5 Gy) recipients. Hematopoietic progenitor cell mobilization was detected from day 3 onwards and prolonged administration of Flt3-ligand produced a steady increase in mobilized progenitor cells. Compared to Flt3-ligand administration for 5 days, the administration of Flt3-ligand for 10 days led to a 5.5-fold increase in cobblestone-area-forming cells at week 4 and a 5.0-fold increase at week 5. Furthermore, transplantation of peripheral blood mononuclear cells mobilized by 5 days of Flt3-ligand administration did not radioprotect lethally irradiated recipients, whereas peripheral blood mononuclear cells mobilized by 10 days of Flt3-Ligand administration did provide 100% radioprotection of the recipients with significant multilineage donor chimerism. Compared to the administration of Flt3-ligand or interleukin-8 alone, co-administration of interleukin-8 and Flt3-ligand led to synergistic enhancement of hematopoietic stem and progenitor cell mobilization on days 3 and 5. These results indicate that hematopoietic stem and progenitor cells show different mobilization kinetics in response to Flt3-ligand, resulting in preferential mobilization of hematopoietic progenitor cells at day 5, followed by hematopoietic stem cell mobilization at day 10.Keywords
This publication has 25 references indexed in Scilit:
- FLT3 receptor and ligand are dispensable for maintenance and posttransplantation expansion of mouse hematopoietic stem cellsBlood, 2009
- Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilizationBlood, 2004
- Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in miceProceedings of the National Academy of Sciences of the United States of America, 2002
- Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF.2000
- The FLT3 ligand potently and directly stimulates the growth and expansion of primitive murine bone marrow progenitor cells in vitro: synergistic interactions with interleukin (IL) 11, IL-12, and other hematopoietic growth factors.The Journal of Experimental Medicine, 1995
- Cloning of the human homologue of the murine flt3 ligand: a growth factor for early hematopoietic progenitor cellsBlood, 1994
- The flt3 ligand: a hematopoietic stem cell factor whose activities are distinct from steel factor.1994
- Molecular cloning of a ligand for the flt3flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cellsCell, 1993
- Clonal analysis of hematopoietic stem-cell differentiation in vivo.Proceedings of the National Academy of Sciences of the United States of America, 1991
- An in vitro limiting-dilution assay of long-term repopulating hematopoietic stem cells in the mouse.1989